Moffitt Cancer Center

Moffitt was named the world’s only Delcath Systems Center of Excellence for our work in percutaneous hepatic perfusion) to treat patients with Metastatic Ocular Melanoma. Moffitt experts train centers from around the world in this newly FDA approved treatment and has treated more patients with this disease type than any other center.

#TheReMissions, Moffitt's house band, are bringing you a limited-edition vinyl holiday album featuring your favorite Christmas classics and holiday season songs. Enjoy the gift of music while supporting cancer research https://lnkd.in/ePpNnWgq Order yours today! ?? Every purchase supports groundbreaking cancer research and highlights the incredible talents of our team.

Join us in congratulating Matthew B. Schabath, Ph.D on receiving the Florida Society of Clinical Oncology (FLASCO) Distinguished Service Award at the recent Fall Meeting!

More than 10,000 participants joined us for the 19th Annual Miles For Moffitt! Together, we raised $1.2 million and counting for lifesaving cancer research. #MilesForMoffitt

Today at #SNO2024, join these experts for the poster session to learn more about their work! Society for Neuro-Oncology ? 11/22 from 7:30 - 9:30 p.m. CST in Hall B3 Catherine Boldig, DO presents a case of hyperbaric oxygen used as a treatment modality for anaplastic astrocytoma. This case concludes that hyperbaric oxygen combined with other treatment modalities may be a promising therapy to improve quality of life. ?? Poster 538 https://lnkd.in/evMcXXRn Catherine Boldig, DO presents a case of metastatic glioblastoma. This case concludes that genetic aberrations such as high copy number and tumor mutational burden have been postulated as facilitators of metastatic potential. ?? Poster 707 https://lnkd.in/e-X2jHjH Adolfo Baez, MD discusses how disseminated Cryptococcus neoformans can mimick the central nervous system progression of diffuse large B-cell lymphoma. This case highlights the risk of opportunistic infections like disseminated Cryptococcus neoformans in immunocompromised patients. ?? Poster 1289 https://lnkd.in/e-9eSfeE Sepideh Mokhtari, MD discusses a case report on refractory Myasthenia Gravis flare induced by an immune check point inhibitor. This case highlights the importance of a comprehensive workup because the patient exhibited symptoms of an immune mediated Triple Overlap Syndrome of Myocarditis, Myositis and Myasthenia. ?? Poster 1188 https://lnkd.in/em__VXYB

Join our team as a full-time Breast Imaging Physician in Diagnostic Imaging. We’re seeking a skilled professional with expertise in multi-modality breast imaging and image-guided biopsies. Make a difference in breast cancer care and apply now! https://lnkd.in/ehGTf7iV

Ready, set, race for hope! Whether in downtown Tampa or participating virtually, let’s unite on November 23 to fuel cancer research at #MilesForMoffitt presented by AutoNation. Register today! https://lnkd.in/eFgDYhWu

Our President & CEO, Patrick Hwu, delivered the keynote at BioFlorida, Inc.'s #BioFL24! He highlighted Moffitt's role in advancing biotech in Florida, including breakthroughs in #CellTherapy and the #SperosFL campus under construction in Pasco County. #FloridaInnovation

Moffitt researchers are investigating a novel cancer vaccine designed to enhance the efficacy of immune checkpoint inhibitors in non-small cell lung cancer. This innovative approach may offer new options for improving patient outcomes in this challenging malignancy. https://lnkd.in/ek7MMd8M

Join us in congratulating Alex Jaeger for being awarded the American Lung Association's Lung Cancer Discovery Award for his research on lung cancer. Thank you for continuing to support cancer research at Moffitt Cancer Center!